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Abstract
Purpose To investigate the differences in brain glucose con-
sumption during olfactory stimulation between subjects af-
fected by multiple chemical sensitivity (MCS) and a group of
healthy individuals.
Methods Two 18F-FDG PET/CT scans were performed in 26
subjects (6 men and 20 women; mean age 46.7±11 years)
with a clinical diagnosis of MCS and in 11 healthy controls (6
women and 5 men; mean age 45.7±11 years), the first scan
after a neutral olfactory stimulation (NS) and the second after
a pure olfactory stimulation (OS). Differences in 18F-FDG
uptake were analysed by statistical parametric mapping
(SPM2).
Results In controls OS led to an increase in glucose consump-
tion in BA 18 and 19 and a reduction in glucose metabolism in
BA 10, 11, 32 and 47. In MCS subjects, OS led to an increase
in glucose consumption in BA 20, 23, 18 and 37 and a
reduction in glucose metabolism in BA 8, 9 and 10.
Conclusion The results of our study suggest that cortical
activity in subjects with MCS differs from that in healthy
individuals during olfactory stimulation.
Keywords PET . Olfactory stimulation .Multiple chemical
sensitivity . Olfactory cortex . Frontal cortex
Introduction
Multiple chemical sensitivity (MCS) is a nonallergic and rela-
tively common chronic disorder in western populations [1]. The
prevalence of self-reported chemical sensitivity symptoms in
population-based studies ranges from 9% to 33 % [1], whereas
the prevalence of physician-diagnosed MCS and of disabling
consequences in the form of social and occupational disruption
are much lower, ranging from 0.5 % to 6.3 % [1–3]. Affected
subjects complain of nonspecific symptoms attributed to expo-
sure to common volatile chemicals, such as fragranced con-
sumer products, tobacco smoke, freshly printed papers, per-
fume and pesticides [1]. The triggered symptoms are various
and include dysosmia, headache, fatigue, respiratory symp-
toms, dizziness and/or nausea [3]. There seems to be no clear
dose–response relationship between exposure and reaction [4]
and no general association between the type of chemical and
symptoms. Surprisingly, individuals with MCS have not been
shown to differ from non-intolerant individuals in terms of
olfactory detection sensitivity or rated intensities of olfactory
stimuli [4].
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In MCS subjects different patterns of cortical and subcor-
tical brain activation occur during olfactory stimulation. In
particular, several perfusional postexposure studies have
shown decreased perfusion in the olfactory, cingulus, hippo-
campus, parahippocampus and temporal cortex regions and in
several subcortical areas [5], and abnormal activation of the
amygdala, piriform cortex, insular cortex and anterior cingu-
late cortex during odour processing [6]. However, in the
previous study normal olfactory performance was demonstrat-
ed using an olfactory screening test in MCS subjects even
though most of these patients reported frequent olfactory
discomfort during daily life [7].
In normal subjects, the processing of odours (that starts in
the olfactory receptor neurons in the olfactory mucosa [8])
mainly involves the piriform cortex, the entorhinal cortex and
the periamygdaloid cortex. These structures have been termed
the olfactory cortex [9]. Several subcortical areas within the
amygdala, including the anterior cortical nucleus and the
nucleus of the lateral olfactory tract are also involved [10,
11]. The olfactory cortex projects to a secondary series of
structures, including the caudal orbitofrontal cortex (OFC)
[9, 10] that receives the majority of corticocortical projections
from the caudal portion of the piriform cortex [10, 12]. This
structure is considered to constitute the secondary olfactory
cortex. Functional imaging studies have shown that the olfac-
tory kinship detection process involves the frontotemporal
junction, the insula and the dorsomedial prefrontal cortex,
but not the primary or secondary olfactory cortices, the related
piriform cortex or the OFC [13] that receive extensive projec-
tions subsequently connecting the caudal OFC to other ana-
tomical subsections of the OFC [9]. Two PET/CTstudies have
shown a significant increase in cerebral blood flow (CBF) in
these cortical areas (especially in the piriform cortex and the
OFC) in healthy subjects, reflecting active recruitment of
these structures during olfactory stimulation [2, 14].
The aim of this study was to compare by means of 18F-FDG
PET/CT the metabolic changes in the brain occurring during
pure olfactory stimulation (OS) with those occurring during
neutral olfactory stimulation (NS) in subjects with MCS and
in a cohort of healthy controls (HC subjects) who were identi-
fied as normosmic by clinical examination since, to the best of
our knowledge, few studies have investigated the usefulness of
this imaging modality in olfactory provocative testing.
Materials and methods
HC and MCS subjects
The HC subjects comprised 11 right-handed individuals (6
women and 5 men; mean age 45.7±11 years) without otorhi-
nolaryngological or neurological diseases. Subjects with dia-
betes, an oncological or HIV history, a neurological or
psychiatric or mood disorder, or a history of surgery, radiation
or trauma to the brain were excluded from the study. More-
over, we did not consider patients undergoing treatment with
drugs that could interfere with 18F-FDG uptake and distribu-
tion in the brain [15]. No patient showed liver or renal impair-
ment, and no patient was pregnant or breastfeeding.
The peripheral blood of MCS and HC subjects was tested
for the usual parameters. The results of all haematological
examinations were normal. A detailed case history was ob-
tained from all subjects. All subjects underwent an ear nose
and throat examination with a fibreoptic check of the upper
airways. The subjects were assessed using the Mini Mental
State Examination and MRI to exclude neurological diseases.
Conditions that could potentially lead to the development of
olfactory dysfunction were considered as exclusion criteria.
Thus, patients with sinonasal disorders or a history of surgery,
head trauma, neuropsychiatric disorder (Parkinson’s disease,
Alzheimer’s disease, schizophrenia, multiple sclerosis and
depression), lower airway and/or lung diseases, active hepati-
tis, cirrhosis, chronic renal failure, vitamin B12 deficiency,
alcohol, tobacco or drug abuse, cerebral vascular accidents,
insulin-dependent diabetes mellitus, hypothyroidism and
Cushing syndrome were not included in the study.
MCS was diagnosed in 26 subjects (6 men and 20 women;
mean age 46.7±11 years) according to the criteria of Cullen
[16]. MCS was confirmed in all subjects by the clinic physi-
cian at the time of recruitment. Both HC and MCS subjects
were evaluated with the multiple forced choice Sniffin’ Sticks
screening test [15] and found to be normosmic.
The Ethics Committee of the Tor Vergata University
School ofMedicine approved the research protocol. The study
adhered to the principles of the Declaration of Helsinki and all
of the participants provided written informed consent.
Olfactory stimulation and 18F-FDG injection
As in our similar study in this field [2], all subjects underwent
18F-FDG PET after receiving the NS which was administered
via a common aerosol facial mask in which the ampoule
contained only 5ml saline (0.9%NaCl; Fig. 1). After 1 month
(to allow sufficient time between radiation exposures), the
subjects underwent a second 18F-FDG PET scan after receiv-
ing a simple OS administered using the same aerosol facial
mask in which the ampoule contained a solution of 1.5 ml
100 % vanillin [Dacor Ltd (http://www.herborientis.com/)
manufactured and Sarandrea Ltd (http://www.sarandrea.it/)
distributed respectively the product that is actually registered
under their co-branding] and 5 ml saline (0.9 % NaCl) [2].
Under both conditions the oxygen flow rate was 3.5 l/min.
Before the stimulation period each patient lay for 30 min with
the eyes closed in a semidarkened and quiet roomwithout any
artificial stimulation. Taking into account the kinetics of 18F-
FDG in the brain (see below) [17–19] and the fact that during
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olfactory experiments subjects may automatically control their
olfactory exposure by altering their respiration and attention to
olfaction during the task condition [20], 18F-FDGwas injected
after 3 min of a continuous 9-min block stimulation with
instructions not to sniff but only inhale the supplied air con-
stantly (see below). The duration of the brain PET acquisition
was 15 min and was started 24 min from the end of the
olfactory stimulation in all the patients, as shown in Fig. 1.
18F-FDG PET/CT
ADiscovery ST16 PET/CTsystem (GEMedical Systems, TN)
was used to assess 18F-FDG brain distribution in all patients
using a 3D-mode standard technique and a 128×128 matrix [2,
21]. Reconstruction was performed using the 3D ordered-
subsets expectation maximization (OSEM) reconstruction
method with 20 subsets and four iterations. The system com-
bines a high-speed ultra 16-detector-row (912 detectors per
row) CT unit and a PET scanner with 10,080 bismuth
germanate crystals in 24 rings (axial full-width at half-
maximum 1-cm radius, 5.2 mm in 3Dmode, axial field of view
157 mm). All MCS and HC subjects fasted for at least 5 h
before intravenous injection of 18F-FDG, and the serum glucose
level was less than 95 mg/ml in all of them. All subjects were
injected intravenously with 185 – 210 MBq of 18F-FDG and
hydrated with 500 ml saline (0.9 % NaCl) [2, 21].
Statistical analysis
Differences in brain 18F-FDG uptake were analysed using
statistical parametric mapping (SPM2; Wellcome Department
of Cognitive Neurology, London, UK) implemented in
Matlab 6.5 (Mathworks, Natick, MA). PET data were sub-
jected to affine and nonlinear spatial normalization into MNI
space. The spatially normalized set of images were then
smoothed with a 12-mm isotropic Gaussian filter to blur
individual variations in gyral anatomy and to increase the
signal-to-noise ratio. Images were globally normalized using
proportional scaling to remove confounding effects on global
cerebral glucose consumption changes, with a masking
threshold of 0.8. The resulting statistical parametric maps,
SPM{t}, were transformed into a normal distribution
(SPM{z}) unit. SPM coordinates were corrected to match
the Talairach coordinates by the subroutine implemented by
Matthew Brett (http://www.mrc-cbu.cam.ac.uk/Imaging).
Brodmann areas (BA) were then identified with a range of 0
to 3 mm from the corrected Talairach coordinates of the SPM
output isocentres, after importing the corrected coordinates,
by Talairach client (http://www.talairach.org/index.html).
In accordance with Bennett et al. [22], SPM t-maps were
thresholded at p<0.05, corrected for multiple comparisons
with the False Discovery Rate (FDR) option at the voxel level
and at p<0.01 corrected for multiple comparison at the cluster
level. Due to the exploratory nature of the study, when statis-
tically significant differences were not found with such con-
servative thresholds a height threshold of p<0.001 uncorrect-
ed at the voxel level was applied. Only those clusters contain-
ing more than 125 (5×5×5 voxels, i.e. 11×11×11 mm) con-
tiguous voxels were accepted as significant, based on the
calculation of the partial volume effect resulting from the
spatial resolution of the PETcamera (about twice the FWHM).
The voxel-based analyses were performed using a ‘two con-
ditions, one scan/condition, paired t-test’ design model. The
following comparisons were assessed: (1) OS vs. NS and vice
versa in HC subjects (Tables 2 and 3), and (2) OS vs. NS and
vice versa in MCS subjects (Tables 4 and 5).
Two-way analysis of variance was used to assess differences
in sex and age. Differences in educational level and occupation
were analysed using Fisher’s exact test. A hypothesis was
considered valid when the p valuewas less than or equal to 0.05.
Results
We did not find statistically significant differences in gender,
age and the main sociodemographic variables between HC
and MCS subjects (Table 1). In HC subjects, the OS led to an
Fig. 1 Olfactory stimulation
study design. The stimulation was
administered via an aerosol facial
mask in which for the OS
condition the ampoule contained
a solution of 1.5 ml 100 %
vanillin and 5 ml saline (0.9 %
NaCl) and for the NS condition
contained only saline solution
without the vanillin
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increase in glucose consumption in the left cerebellum occip-
ital lobe bilaterally and the left limbic lobe (BA 18 and 19;
Table 2 and Fig. 2) and a reduction in glucose metabolism in a
large portion of the left frontal and left limbic lobes (BA 10,
11, 32, 38 and 47; Table 3, Fig. 2).
In MCS subjects, OS led to an increase in glucose con-
sumption in the left temporal and occipital lobe bilaterally
(BA 20, 23, 18 and 37; Table 4 and Fig. 2) and to a reduction
in glucose metabolism in the frontal lobe bilaterally (BA 8, 9
and 10; Table 5 and Fig. 2).
With the exception of the results shown in Table 2 (OS vs. NS
comparison in HC subjects), 18F-FDG uptake was not signifi-
cantly increased or decreased in any subcortical area (Fig. 2).
Discussion
In HC subjects OS led to an increase in glucose consumption
in the cuneus, lingual gyrus and parahippocampal region
(Table 2), areas that are actively involved in olfaction
[8–12]. Our findings are in agreement with those of other
functional studies (perfusional PET and SPECT, fMRI) per-
formed during OS in healthy individuals [5, 6, 23–25]. In HC
subjects OS led to a decrease in metabolism in several frontal
areas including a large portion of the superior and middle
frontal gyrus and OFC in agreement with the findings of a
previous study (Table 3 and Fig. 2) [2].
Intensive activation/deactivation in the left orbitofrontal
gyrus (BA 11 and 47) has been found during emotionally
valenced olfactory stimuli suggesting that pleasant and un-
pleasant emotional judgments are related to recruitment of
these areas in the left hemisphere [26]. Several studies have
shown that alterations in neural responses are specific to the
judgments that will be made about an olfactory stimulus, since
the pattern of brain activity induced in one task may not be
present during other tasks. In a study in which subjects were
asked to perform a task involving pleasantness, fMRI revealed
that the medial OFC and pregenual cingulate cortex were
activated, while an intensity task resulted in activation of the
inferior frontal gyrus [27]. These differences in brain
activation began before odour delivery, in an anticipatory
fashion following the instructions, suggesting attentional bi-
asing of incoming information in a way that matched the
instructions [27]. These findings support previous work indi-
cating that subjective affective judgments activate the second-
ary olfactory cortex while sensory information is processed in
the primary olfactory cortex [28].
Gottfried and Zald showed that lateral and anterior regions
of the OFC respond in a preferential manner to binary odour
mixtures [29]. By investigating regional CBF in the lateral and
anterior OFC, they found that these two regions respond to
odour mixtures in different ways. Specifically, activation in
the lateral OFC increased with increasing odorant impurity.
On the other hand, the anterior region of the OFC was equally
activated by binary odour mixtures and deactivated by single
odours [29]. Interestingly, these data were further confirmed
by Boyle et al. who found that the anterior OFC acts as a sort
of on/off switch and this region is similarly activated in
response to all odour mixtures and deactivated in response
to single odorants [30].
In MCS subjects, a different cortical activation pattern was
found during olfactory stimulation (Table 2 and 4, Fig. 2). On
the one hand, a similar activation pattern involved both the
cuneus and lingual gyrus, and on the other hand, as shown in
Table 4, activation of the left inferior temporal gyrus (BA 20)
was seen inMCS subjects in contrast to HC subjects. This area
is widely connected to the visual cortex, playing a key role in
the visual association process [31]. A study performed in
subjects with dementia has shown a key role of this brain
structure in the cognitive process, with the cortical atrophy of
the left inferior temporal gyrus being related to cortical atro-
phy in deep structures such as the entorhinal cortex and
amygdala [32].
Our findings are in partial disagreement with those of the
study by Orriols et al. [5, 6]. In their study investigating brain
perfusion patterns in a population of five MCS subjects pas-
sively breathing a substance able to trigger the syndrome,
Orriols et al. did not find any area of significant major brain
activity [5]. On the other hand, investigating a larger popula-
tion of patients (12 patients), Hillert et al. found that although
Table 1 Characteristics of the
study population, including
sociodemographic variables
MCS subjects HC subjects
Male Female p value Male Female p value
Age (years), mean±SD 45.6±9 47.6±12 0.88; 1 42.7±14.5 48.2±8 0.84; 1
Education
Below university level 4 13 1 4 3 0.54
University level or above 2 7 1 3
Occupation
Manual 0 3 1 2 2 1
Skilled 6 18 3 4
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odour-processing brain regions were activated less in MCS
subjects than in controls, there was a significant odorant-
related increase in activation of the anterior cingulate cortex
and cuneus-precuneus, in agreement with the results of our
study [6].
In MCS subjects a significant odour-induced deactivation
occurred in a large portion of the frontal lobe bilaterally (BA 8,
9 and 10). While other studies have shown a wide cortical
deactivation (parietal, temporal and occipital areas) in MCS
subjects exposed to odours (acetone) [6], only significant
frontal deactivation occurred in MCS subjects in our study
(Table 5). Possible explanations for these discrepancies could
be related (1) to the type of odorant delivered in the present
and the previous study [2] compared to other similar studies
[23, 24, 26, 28, 33], and (2) to the particular resting condition
in which subjects underwent odorant stimulation. Regarding
the first explanation, most compounds used in many studies,
such as that of Hillert et al. [6], were acetone (with strong
Table 2 Results of SPM comparisons for olfactory vs. neutral stimulation inHC subjects (areas of increased 18F-FDGuptake during olfactory stimulation)
Cluster levela Voxel levelb
Cluster extent
(no. of voxels)
Corrected
p value
Cortical region Z score of
maximum
MNI coordinates Cortical region BA
4,008 0.000 Left cerebellum 3.86 −16, −74, −24 Declive of the cerebellum –
Left occipital lobe 3.66 −2, −102, 0 Cuneus 18
Left occipital lobe 3.16 −2, −98, 18 Lingual gyrus 18
Right occipital lobe 3.09 12, −76, −4 Lingual gyrus 18
Left limbic lobe 2.50 −22, −54, −8 Parahippocampal gyrus 19
p<0.001 and p≤0.05 uncorrected for multiple comparisons were accepted as statistically significant at the voxel level and cluster level, respectively
a The number of voxels, the corrected p value and the cortical region where the voxel was found are reported for each significant cluster
b All coordinates of the correlation sites with the Z score of the maximum correlation point, the corresponding cortical region and BA are reported for
each significant cluster. If the maximum correlation was outside the grey matter, the nearest grey matter (within a range of 5 mm) is indicated with the
corresponding BA
Fig. 2 SPM2 output images: a–c
OS vs. NS in HC subjects
(Table 2); d–f NS vs. OS in HC
subjects (Table 3); g–i OS vs. NS
in MCS subjects (Table 4); l–n)
NS vs. OS in MCS subjects. Note
that the cerebellar areas shown in
g and h did not reach statistical
significance
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trigeminal properties), vanillin and four other odorants (cedar
oil, lavender oil, eugenol and butanol), mainly undiluted [6].
With respect to the second explanation, for the first time in the
present study, a large group of MCS subjects underwent
olfactory stimulation under resting conditions decoupled from
the acquisition phase. Thus were able to create a defined
ecological baseline condition to explore olfactory neural un-
derpinnings, avoiding possible cortical activation related to
unwanted attentional processes and odour sensitivity enhance-
ment due to the examination environment [34].
Contrary to the description of symptoms in this pa-
thology (that suggests neuronal sensitization as one of
the main features [16, 35]), subjects with MCS showed
reduced rather than enhanced activation of cerebral re-
gions responsible of secondary processing of odour sig-
nals. In particular, as compared to HC subjects, several
differences in these deactivation patterns during olfactory
stimulation occurred in MCS subjects (Tables 3 and 5).
MCS subjects showed reduced glucose consumption in
BA 8, 9 and 10 while in HC showed reduced glucose
metabolism in BA 11, 32, 38 and 47. The intensive
deactivation in the PFC in MCS subjects is not surpris-
ing since this structure shows intensive interconnections
with the amygdala, hypothalamus, midbrain and pons,
Table 3 Results of SPM comparisons for neutral vs. olfactory stimulation inHC subjects (areas of increased 18F-FDGuptake during olfactory stimulation)
Cluster levela Voxel levelb
Cluster extent
(no. of voxels)
Corrected
p value
Cortical region Z score of maximum Talairach coordinates Cortical region BA
2,060 0.041 Left frontal lobe 4.15 −29, −84, −2 Middle frontal gyrus 10
Left frontal lobe 3.62 −23, 35, −4 Middle frontal gyrus 11
Left frontal lobe 3.43 −28, 24, −17 Inferior frontal gyrus 11
Left frontal lobe 3.25 −12, 48, 12 Medial frontal gyrus 10
Left frontal lobe 2.96 −18, 22, −22 Orbital gyrus 47
Left limbic lobe 2.93 −20, 40, 6 Anterior cingulate 32
Left frontal lobe 2.80 −22, 62, 6 Superior frontal gyrus 10
Left frontal lobe 2.55 −35, 35, 3 Middle frontal gyrus 47
Left frontal lobe 2.54 −14, 42, 10 Superior frontal gyrus 11
p<0.001 and p≤0.05 uncorrected for multiple comparisons were accepted as statistically significant at the voxel level and cluster level, respectively
a The number of voxels, the corrected p value and the cortical region where the voxel was found are reported for each significant cluster
b All coordinates of the correlation sites with the Z score of the maximum correlation point, the corresponding cortical region and BA are reported for
each significant cluster. If the maximum correlation was outside the grey matter, the nearest grey matter (within a range of 7 mm) is indicated with the
corresponding BA
Table 4 Results of SPMcomparisons for olfactory vs. neutral stimulation inMCS subjects (areas of increased 18F-FDGuptake during olfactory stimulation)
Cluster levela Voxel levelb
Cluster extent
(no. of voxels)
Corrected
p value
Cortical region Z score of
maximum
Talairach
coordinates
Cortical region BA
2,089 0.000 Left temporal lobe 4.48 24, 40, 29 Inferior temporal gyrus 20
Left occipital lobe 3.77 50, 34, 20 Cuneus 23
Left temporal lobe 4.48 24, 40, 29 Inferior temporal gyrus 20
Right occipital lobe 3.77 50, 34, 20 Lingual gyrus 18
Left occipital lobe 3.77 50, 34, 20 Cuneus 18
Left temporal lobe 4.48 24, 40, 29 Inferior temporal gyrus 37
p<0.001 and p≤0.05 uncorrected for multiple comparisons were accepted as statistically significant at the voxel level and cluster level, respectively
a The number of voxels, the corrected p value and the cortical region where the voxel was found are reported for each significant cluster
b All coordinates of the correlation sites with the Z score of the maximum correlation point, the corresponding cortical region and BA are reported for
each significant cluster. If the maximum correlation was outside the grey matter, the nearest grey matter (within a range of 7 mm) is indicated with the
corresponding BA
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and is likely to integrate higher-order brain functions
with more developmentally fundamental brain activities
such as emotional, visceral or autonomic functions [36]
and changes in CBF in this region have already been
shown during OS in MCS subjects [33].
During OS, MCS subjects did not show deactivation
of the superior temporal gyrus (BA 38), anterior cingu-
late cortex (BA 32) or middle frontal gyrus (BA 47) in
contrast to HC subjects (Tables 3 and 5, Fig. 2), further
confirming a different metabolic processing of odour
signals as a main characteristic of MCS [6] and ruling
out the hypothesis that MCS may be a purely psychoso-
matic disorder with somatic distress upon exposure to
odours [37].
Finally, the detection in our case studies of several second-
ary olfactory areas in both HC and MCS subjects [8–12, 26]
may be due to the relatively slow kinetics of 18F-FDG, that
shows activation/deactivation of those areas that are activated
late during stimulation and prior to image acquisition, and this
is a possible limitation of our study [17–19]. Indeed, the
results of the comparison between the metabolic activity in
normosmic individuals undergoing an OS and that in
normosmic individuals not receiving any OS indicate in-
creased activity in regions associated with OS (i.e. prefrontal,
parietal, insular and temporal right hemisphere cortices) which
is in accordance with the existing neuroimaging literature on
olfactory activation [5, 6, 23–25].
The results of this study suggest that 18F-FDG PET/CT
may be a suitable methodology for investigating brain meta-
bolic cortical changes during olfactory tasks. Future studies
could evaluate the usefulness of this imaging modality for the
investigation of the impact of other stimuli (i.e. visual or
auditory) on brain glucose consumption.
Conclusion
The results of this study suggest that brain metabolism differs
between HC and MCS subjects during OS, suggesting that
MCS subjects process odours differently from HC subjects. In
particular, cortical odour processing in MCS subjects is char-
acterized by deactivation that mainly involves the frontal
cortex and by active recruitment of the left inferior temporal
gyrus. 18F-FDG PET/CT may be a useful imaging modality
for investigating variations in brain activity during olfactory
tasks.
Conflicts of interest None.
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